Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ElleVet Feline is a line of hemp-derived cannabinoid products specifically formulated for cats by ElleVet Sciences. The products utilize a proprietary "Complete Spectrum" hemp oil blend, where approximately 90% of the cannabinoid profile consists of cannabidiol (CBD) and cannabidiolic acid (CBDA), supplemented by other minor cannabinoids. These products are designed to support feline health in areas such as mobility, stress management, and cognitive function. The mechanism of action involves the interaction of these cannabinoids with the feline endocannabinoid system to maintain physiological balance and homeostasis. ElleVet Feline is available in multiple dosage forms, including pastes, oils, soft gels, and soft chews, and is noted for being backed by long-term safety data specifically in cats.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ElleVet Feline.